Evolution News and Research

RSS

New finding could help change pharmaceutical treatment of neurodegenerative diseases

Diseases like Alzheimer's are caused when proteins aggregate and clump together. In a world first, EPFL scientists have successfully distinguished between the disease-causing aggregation forms of proteins.

28 Jul 2015

Study findings could lead to new ways to tailor therapies for cancer

By studying the yeast used in beer- and bread-making, researchers at the University of Pittsburgh School of Medicine have uncovered the mechanism by which ancient proteins repair DNA damage and how their dysfunction could lead to the development of tumors.

28 Jul 2015

Innovative new devices that facilitate IA treatment improve outcomes, decrease mortality rates

In the last decade, Intra-Arterial (IA) stroke therapy (a technique in which thrombolytic agents and devices are passed through the arteries directly to the clot site) has gained notable momentum as an effective and safe treatment option for patients.

28 Jul 2015

Recipients of GSA poster awards announced at 20th International C. elegans Meeting

The Genetics Society of America and the C. elegans research community are pleased to announce the recipients of the GSA poster awards at the 20th International C. elegans Meeting, which took place at the University of California, Los Angeles, June 24-28, 2015.

28 Jul 2015

UO researchers to examine effects of climate change on indoor air quality

University of Oregon researchers and industry partners are exploring how indoor home microbial environments change -- and what that means to human health -- when whole-house weatherization projects are implemented.

28 Jul 2015

Necrotising autoimmune myopathy requires early, aggressive treatment

Researchers call for the prompt recognition of necrotising autoimmune myopathy and aggressive early treatment with a combination of intravenous immune globulin, corticosteroids and a steroid-sparing agent for 3 months.

27 Jul 2015

MSU scientists suggest that common glaucoma medication could be used to treat TB

A new discovery by Michigan State University scientists suggests that a common medication used to treat glaucoma could also be used to treat tuberculosis, even the drug-resistant kind.

24 Jul 2015

Scientists discover genetic markers for mosquito resistance to insecticides

Controlling mosquitoes that carry human diseases is a global health challenge as their ability to resist insecticides now threatens efforts to prevent epidemics. Scientists from the CNRS, IRD, Université Claude Bernard Lyon 1, Université Joseph Fourier in Grenoble and Institut Pasteur in French Guiana have identified new genetic markers for mosquito resistance to insecticides, which could improve its detection in the field.

24 Jul 2015

Deep Genomics set to bring the power of deep learning technologies to genomics

Evolution has altered the human genome over hundreds of thousands of years -- and now humans can do it in a matter of months.

23 Jul 2015

Direct Relief honored with Esri's Special Achievement in GIS Award

Direct Relief was honored by Esri today with a Special Achievement in GIS Award for its role in developing map applications for the One-Million Community Health Workers campaign (1mCHW), a joint initiative of the Sustainable Development Solutions Network and the Earth Institute at Columbia University.

23 Jul 2015

Late- and post-menopausal women have more fat around hearts compared to pre-menopausal counterparts

Late- and post-menopausal women have significantly greater volumes of fat around their hearts - a risk factor for heart disease - than their pre-menopausal counterparts, a University of Pittsburgh Graduate School of Public Health study has shown for the first time.

23 Jul 2015

New model helps to answer longstanding question in cancer science

A paper published today in the Proceedings of the National Academy of Sciences argues against the commonly held "accumulation of mutations" model of oncogenesis in favor of a model that depends on evolutionary pressures acting on populations of cells.

22 Jul 2015

UChicago, Argonne National Laboratory and USF to jointly study gut microbiomes of premature infants

Scientists have suspected that this initial disruption is linked to health problems down the road—things like autism, asthma, food allergies and autoimmune diseases—but so far they only have circumstantial evidence based on case studies.

17 Jul 2015

Protagonist Therapeutics closes $40 million Series C financing

Protagonist Therapeutics, Inc., a company developing novel, orally stable peptide therapeutics for gastrointestinal diseases and disorders, today announced the closing of a $40 million Series C financing.

16 Jul 2015

Key parts of the human brain network give power to control, redirect attention

Researchers at Columbia University Medical Center have found that key parts of the human brain network that give us the power to control and redirect our attention--a core cognitive ability--may be unique to humans.

16 Jul 2015

Connexient, RWJUH announce public launch of MediNav Navigator Edition 2.0

Connexient and Robert Wood Johnson University Hospital announced this week the public launch of MediNav Navigator Edition 2.0. This makes RWJUH the first hospital in North America to deliver for its patients, visitors and staff the world's first true turn-by-turn indoor navigation smartphone application, with reliable indoor positioning accuracy of one to two meters.

10 Jul 2015

International research team identifies new gene associated with 4H leukodystrophy

Leukodystrophies are deadly neurodegenerative diseases that affect one in 7,000 children and remain incurable. These genetic diseases attack myelin or the "insulating rubber sheath" surrounding neurons, which leads to deteriorating health for affected children.

9 Jul 2015

Galmed signs License Agreement for development of blood-based companion diagnostic tool

Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on the development and commercialization of a once-daily, oral therapy for the treatment of liver diseases, announced today that it has entered into a Research, Option and License Agreement ("License Agreement") and a Share Purchase Agreement with One Way Liver Genomics S.L., for the development of a non-invasive, blood-based companion diagnostic tool.

8 Jul 2015

Evidence-based initiative aims to prevent avoidable hospital readmissions

A statewide effort led by key stakeholders in South Carolina successfully organized and implemented an evidence-based initiative aimed at improving the quality of healthcare transitions after hospital discharge to prevent avoidable readmissions.

8 Jul 2015

Study sheds light on how dengue virus adapts, causes outbreaks as it travels

A researcher from The University of Texas Medical Branch at Galveston is an integral member of a collaborative group that is the first to explain the mechanisms that the Dengue virus has developed to optimize its ability to cause outbreaks as it travels across the globe to new places and revisits old ones.

7 Jul 2015

Evolution News and Research

New finding could help change pharmaceutical treatment of neurodegenerative diseases

Study findings could lead to new ways to tailor therapies for cancer

Innovative new devices that facilitate IA treatment improve outcomes, decrease mortality rates

Recipients of GSA poster awards announced at 20th International C. elegans Meeting

UO researchers to examine effects of climate change on indoor air quality

Necrotising autoimmune myopathy requires early, aggressive treatment

MSU scientists suggest that common glaucoma medication could be used to treat TB

Scientists discover genetic markers for mosquito resistance to insecticides

Deep Genomics set to bring the power of deep learning technologies to genomics

Direct Relief honored with Esri's Special Achievement in GIS Award

Late- and post-menopausal women have more fat around hearts compared to pre-menopausal counterparts

New model helps to answer longstanding question in cancer science

UChicago, Argonne National Laboratory and USF to jointly study gut microbiomes of premature infants

Protagonist Therapeutics closes $40 million Series C financing

Key parts of the human brain network give power to control, redirect attention

Connexient, RWJUH announce public launch of MediNav Navigator Edition 2.0

International research team identifies new gene associated with 4H leukodystrophy

Galmed signs License Agreement for development of blood-based companion diagnostic tool

Evidence-based initiative aims to prevent avoidable hospital readmissions

Study sheds light on how dengue virus adapts, causes outbreaks as it travels

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News